144 related articles for article (PubMed ID: 16391840)
21. IL-10 overexpression differentially affects cartilage matrix gene expression in response to TNF-alpha in human articular chondrocytes in vitro.
Müller RD; John T; Kohl B; Oberholzer A; Gust T; Hostmann A; Hellmuth M; Laface D; Hutchins B; Laube G; Veh RW; Tschoeke SK; Ertel W; Schulze-Tanzil G
Cytokine; 2008 Dec; 44(3):377-85. PubMed ID: 19026560
[TBL] [Abstract][Full Text] [Related]
22. STAT3-decoy ODN inhibits cytokine autocrine of murine tumor cells.
Liu X; Li J; Zhang J
Cell Mol Immunol; 2007 Aug; 4(4):309-13. PubMed ID: 17764622
[TBL] [Abstract][Full Text] [Related]
23. Ceramide inhibits LPS-induced production of IL-5, IL-10, and IL-13 from mast cells.
Chiba N; Masuda A; Yoshikai Y; Matsuguchi T
J Cell Physiol; 2007 Oct; 213(1):126-36. PubMed ID: 17458900
[TBL] [Abstract][Full Text] [Related]
24. Prostaglandin E1 inhibits IL-6-induced MCP-1 expression by interfering specifically in IL-6-dependent ERK1/2, but not STAT3, activation.
Sobota RM; Müller PJ; Heinrich PC; Schaper F
Biochem J; 2008 May; 412(1):65-72. PubMed ID: 18271757
[TBL] [Abstract][Full Text] [Related]
25. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
[TBL] [Abstract][Full Text] [Related]
26. SK-126, a synthetic compound, regulates the production of inflammatory cytokines induced by LPS in antigen-presenting cells.
Kang K; Kim H; Kim KI; Yang Y; Yoon DY; Kim JH; Ryu JH; Noh EJ; Jeon SD; Lim JS
Biochem Pharmacol; 2008 Mar; 75(5):1054-64. PubMed ID: 18054895
[TBL] [Abstract][Full Text] [Related]
27. Is there an interaction between interleukin-10 and interleukin-22?
Wolk K; Witte E; Reineke U; Witte K; Friedrich M; Sterry W; Asadullah K; Volk HD; Sabat R
Genes Immun; 2005 Feb; 6(1):8-18. PubMed ID: 15526001
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of IL-10 receptor by epithelial cells and alveolar macrophages.
Lim S; Caramori G; Tomita K; Jazrawi E; Oates T; Chung KF; Barnes PJ; Adcock IM
Allergy; 2004 May; 59(5):505-14. PubMed ID: 15080831
[TBL] [Abstract][Full Text] [Related]
29. An RNA-binding protein alphaCP-1 is involved in the STAT3-mediated suppression of NF-kappaB transcriptional activity.
Nishinakamura H; Minoda Y; Saeki K; Koga K; Takaesu G; Onodera M; Yoshimura A; Kobayashi T
Int Immunol; 2007 May; 19(5):609-19. PubMed ID: 17383969
[TBL] [Abstract][Full Text] [Related]
30. Lack of response of rat chondrosarcoma chondrocytes to interleukin-1 to produce proteoglycan- and collagen-degrading enzymes.
DiPasquale G; Caccese R; Pasternak R; Caputo CB; Conaty J; Hubbs S
Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):333-9. PubMed ID: 3526479
[TBL] [Abstract][Full Text] [Related]
31. The role of NF-kappaB in mediating the anti-inflammatory effects of IL-10 in intestinal epithelial cells.
Al-Ashy R; Chakroun I; El-Sabban ME; Homaidan FR
Cytokine; 2006 Oct; 36(1-2):1-8. PubMed ID: 17161612
[TBL] [Abstract][Full Text] [Related]
32. Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response.
Murray PJ
Curr Opin Pharmacol; 2006 Aug; 6(4):379-86. PubMed ID: 16713356
[TBL] [Abstract][Full Text] [Related]
33. Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-kappaB and p38.
Hiramitsu T; Yasuda T; Ito H; Shimizu M; Julovi SM; Kakinuma T; Akiyoshi M; Yoshida M; Nakamura T
Rheumatology (Oxford); 2006 Jul; 45(7):824-32. PubMed ID: 16449361
[TBL] [Abstract][Full Text] [Related]
34. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis.
Nowell MA; Richards PJ; Fielding CA; Ognjanovic S; Topley N; Williams AS; Bryant-Greenwood G; Jones SA
Arthritis Rheum; 2006 Jul; 54(7):2084-95. PubMed ID: 16802343
[TBL] [Abstract][Full Text] [Related]
35. Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation.
Sakurai N; Kuroiwa T; Ikeuchi H; Hiramatsu N; Maeshima A; Kaneko Y; Hiromura K; Nojima Y
Rheumatology (Oxford); 2008 Jun; 47(6):815-20. PubMed ID: 18397956
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-10 induces apoptosis in developing mast cells and macrophages.
Bailey DP; Kashyap M; Bouton LA; Murray PJ; Ryan JJ
J Leukoc Biol; 2006 Sep; 80(3):581-9. PubMed ID: 16829633
[TBL] [Abstract][Full Text] [Related]
37. Delta-4 expression on a stromal cell line is augmented by interleukin-6 via STAT3 activation.
Suzuki M; Yamamoto M; Sugimoto A; Nakamura S; Motoda R; Orita K
Exp Hematol; 2006 Sep; 34(9):1143-50. PubMed ID: 16939807
[TBL] [Abstract][Full Text] [Related]
38. Auranofin blocks interleukin-6 signalling by inhibiting phosphorylation of JAK1 and STAT3.
Kim NH; Lee MY; Park SJ; Choi JS; Oh MK; Kim IS
Immunology; 2007 Dec; 122(4):607-14. PubMed ID: 17645497
[TBL] [Abstract][Full Text] [Related]
39. Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis.
van Lent PL; Grevers LC; Blom AB; Arntz OJ; van de Loo FA; van der Kraan P; Abdollahi-Roodsaz S; Srikrishna G; Freeze H; Sloetjes A; Nacken W; Vogl T; Roth J; van den Berg WB
Arthritis Rheum; 2008 Dec; 58(12):3776-87. PubMed ID: 19035520
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta.
Raymond L; Eck S; Mollmark J; Hays E; Tomek I; Kantor S; Elliott S; Vincenti M
J Cell Physiol; 2006 Jun; 207(3):683-8. PubMed ID: 16453302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
